Prognostic value of electroneurography in Bell's palsy and Ramsay–Hunt's syndrome
Transcript of Prognostic value of electroneurography in Bell's palsy and Ramsay–Hunt's syndrome
Prognostic value of electroneurography in Bell’s palsy andRamsay–Hunt’s syndrome
Lee, D.-H., Chae, S.-Y., Park, Y.-S., & Yeo, S.-W.
Department of Otolaryngology – Head and Neck Surgery, College of Medicine, The Catholic University of Korea,
Seoul, South Korea
Accepted 29 December 2005
Clin. Otolaryngol 2006, 31, 144–148
Objectives: This study evaluated the accuracy of electro-
neurography to predict the prognosis of Bell’s palsy and
Ramsay–Hunt’s syndrome.
Design: A retrospective, institutional review board-
approved study.
Setting: A secondary referral and a university-based
centre.
Participants: The patients had been treated for a sudden
onset unilateral facial paralysis over the past 10 years
(1994–2004). This retrospective study included only those
patients who had been followed up for at least 3 months
or if they had reached a complete recovery before then.
Main outcomes measures: House–Backmann grade versus
electroneurography value.
Results: The recovery rates to House–Brackmann grade II
or better were 95% in those with Bell’s palsy and 84% in
those with herpes zoster oticus. The electroneurography
value of the recovery and non-recovery groups from
those with either Bell’s palsy or herpes zoster oticus was
similar. The logistic regression model between the electro-
neurography values and the probability of recovery
showed no correlation in those with Bell’s palsy or with
herpes zoster oticus. This study did not identify the
proper electroneurography value that had enough appro-
priate sensitivity and specificity to predict the prognosis
of paralysis accurately in Bell’s palsy or in herpes zoster
oticus patients.
Conclusion: Electroneurography performed between
day 7 and 10 for Bell’s palsy or day 10 and 14 for
herpes zoster oticus does not provide accurate
information on the prognosis or recovery rate of the
facial paralysis.
Acute peripheral facial paralysis is a rare disease in oto-
laryngology, with an estimated incidence of �30 patients
per 100 000 populations annually. Facial paralysis is an
extremely frightening situation for patients. It can cause
extreme stress as a result of the obvious disfiguring
facial expression, which may cause significant functional,
aesthetic, and psychological disturbances to the patient.
Because the psychological stress of patients with acute
facial palsy is generally high on the first hospital visit,
the questions most frequently asked by these patients
are whether or not their facial function will return to
normal, how much of their facial function will be recov-
ered, and how long is this going to take, suggesting that
clinicians must also treat the psychological aspects of
this manifestation by adequately explaining the progno-
sis, in addition to providing the appropriate medical
therapy.
For decades, physicians have searched for prognostic
tests of sufficient accuracy to serve the obvious need for
information. Since the early 1970s when Esslen1 introduced
the use of electroneurography, prognostication has been
based mainly on various electrophysiologic tests, including
the nerve excitability test, the maximal stimulation test,
and electromyography. In particular, electroneuro-
graphy can determine the percentage of fibres that have
degenerated, and various studies have shown that electro-
neurography can be used to predict the prognosis of acute
facial palsy,2–7 and May et al.8 reported that degeneration
£25% within the first 2 weeks of onset indicated a satisfac-
tory restoration of the facial function in 98% of Bell’s palsy
patients. However, these studies targeted only those with
Bell’s palsy or traumatic palsy, and did not include those
with herpes zoster oticus, which is the second most com-
mon cause of facial paralysis. In addition, they did not
report the subdivided prognostic profiles in the case of
degeneration not exceeding 25% within the first 2 weeks of
onset.
Correspondence: Dr D.-H Lee, Department of Otolaryngology – Head
and Neck Surgery, The Catholic University of Korea, Uijeongbu
St Mary’s Hospital, 65–1 Gumoh-Dong, Uijeongbu City, Gyeonggi-Do,
480–130, South Korea, Tel.: 82-31-820-3564; fax: 82-31-847-0038;
e-mail: [email protected]
OR
IG
IN
AL
AR
TIC
LE
144 � 2006 The Authors. Journal compilation � 2006 Blackwell Publishing Limited, Clinical Otolaryngology, 31, 144–148
The aims of this study in patients with Bell’s palsy and
Ramsay–Hunt’s syndrome were: (1) to evaluate the corre-
lation between the electroneurography results and the
prognosis; and (2) to determine the validity of electro-
neurography as a prognostic indicator.
Subjects and methods
Patients inclusion
This study enrolled patients treated for a sudden onset
unilateral facial paralysis between 1994 and 2004 at the
Otolaryngology – Head and Neck Surgery Department in
Uijeongbu St Mary’s Hospital, which is a secondary refer-
ral and a university-based centre. The medical records of
these patients were screened retrospectively. A diagnosis
of Bell’s palsy and herpes zoster oticus was confirmed by
a clinical examination, blood laboratory tests including
those for the herpes zoster virus and radiological studies
including magnetic resonance imaging. Patients with
facial paralysis resulting from other causes were excluded.
This retrospective study included only those patients who
could be followed up for at least 3 months or if they had
reached a complete recovery before then.
House–Brackmann grading
The status of the facial nerve function was documented
using the House–Brackmann grading system (Table 1).9
The ‘initial status’ was defined as the worst House–Brack-
mann grade after the facial paralysis had developed, and
the ‘last status’ was defined as the House–Brackmann
grade at the time of either complete recovery or the
patient’s final visit. The ‘degree of recovery’ was defined
as the difference between the initial and final status.
Those patients whose final status was less than the initial
status were grouped into the ‘recovery group’ and those
patients whose final status was House–Brackmann grade I
were classified into the ‘complete-recovery group’.
Electroneurography
The electroneurography was performed 7–10 days after
onset in the Bell’s palsy patients and 10–14 days after
onset in the herpes zoster oticus patients. The percent-
age of fibres remaining was calculated by dividing the
amplitude of the compound action potential of the
paralysed side by that of the normal side, multiplied by
100.
Table 1. House–Brackmann facial nerve grading system
Grade Defined by
1 Normal Normal facial function in all areas
2 Mild dysfunction Slight weakness noticeable only on close inspection
At rest: normal symmetry of forehead, ability to close eye with minimal effort and slight
asymmetry, ability to move corners of mouth with maximal effort and slight asymmetry
No synkinesis, contracture, or hemifacial spasm
3 Moderate dysfunction Obvious but not disfiguring difference between two sides, no functional impairment;
noticeable but not severe synkinesis, contracture, and/or hemifacial spasm
At rest: normal symmetry and tone. Motion: slight to no movement of forehead,
ability to close eye with maximal effort and obvious asymmetry, ability to move
corners of mouth with maximal effort and obvious asymmetry
Patients who have obvious but not disfiguring synkinesis, contracture, and/or
hemifacial spasm are grade III regardless of degree of motor activity
4 Moderately severe dysfunction Obvious weakness and/or disfiguring asymmetry
At rest: normal symmetry and tone. Motion: no movement of forehead; inability to close
eye completely with maximal effort.
Patients with synkinesis, mass action, and/or hemifacial spasm severe enough to
interfere with function are grade IV regardless of motor activity
5 Severe dysfunction Only barely perceptible motion
At rest: possible asymmetry with droop of corner of mouth and decreased or absence of nasal
labial fold
Motion: no movement of forehead, incomplete closure of eye and only slight movement of lid
with maximal effort, slight movement of corner of mouth
Synkinesis, contracture, and hemifacial spasm usually absent
6 Total paralysis Loss of tone; asymmetry; no motion; no synkinesis, contracture, or hemifacial spasm
ENoG in peripheral facial palsy 145
� 2006 The Authors. Journal compilation � 2006 Blackwell Publishing Limited, Clinical Otolaryngology, 31, 144–148
Treatment protocol
Uniform treatments were given to all patients diagnosed
with either Bell’s palsy or herpes zoster oticus, and they
were admitted for 10 days. The treatments given to the
patients were physical and psychological rest; low-salt and
high-protein diets; carbogen therapy; protective eye care
including the application of artificial eye drops for day-
time use and eye ointment for nighttime; the use of adhe-
sive tape to close the paralysed eyelid during sleep;
stellate ganglion block therapy, and exercise to maintain
the tone of the facial muscles by physical therapy. The
medical treatments consisted of high-dose prednisolone
and peripheral vasodilators orally, in combination with
dextran intravenously. Acyclovir i.v. was administered to
the herpes zoster oticus patients. The prednisolone dose
was 1 mg/kg body weight per a day for 5 days. There-
after, the dose was tapered for further 5 days. The acyclo-
vir dose was 5 mg/kg body weight every 8 h for 5 days.
Afterward, acyclovir was administered orally at a dose of
400 mg t.i.d. for a further 7 days.
Statistical analysis
The data in this study are reported as a mean ± SD. All
the statistical analyses were performed using the spss
software program (SPSS Inc., Chicago, IL, USA), and a
P-value < 0.05 was considered significant.
Ethical considerations
Institutional review board approval of Uijeongbu St
Mary’s Hospital was obtained for this study. Patient
informed consent was not required by the institutional
review board.
Results
Bell’s palsy
Patients. During the study period, 110 Bell’s palsy
patients were admitted for treatment. The patients who
were lost after discharge were excluded and 55 Bell’s
palsy patients met the inclusion criteria. There was no
significant difference of initial status between admission
group (110 patients) and study group (55 patients)
(chi-square test; P ¼ 0.32). All of Bell’s palsy patients
had magnetic resonance imaging performed to rule out
other causative lesions. Electroneurography was per-
formed in 40 patients. The Bell’s palsy group consisted
of 17 males and 23 females with a mean age of
36.4 years (SD, 18.2 years). The right and left side were
involved in 28 and 12 patients, respectively. There was
no significant difference of initial and final status
between total group and electroneurography group (chi-
square test; P ¼ 0.74). Table 2a shows the initial and
final status of the Bell’s palsy. The chance of a complete
recovery was estimated to be 53% in the Bell’s palsy
group (Fig. 1a).
Correlation between the House–Brackmann grade and elec-
troneurography value. A Mann–Whitney test was used to
analyse the difference in the electroneurography value
according to whether or not there was a recovery. In the
Bell’s palsy group, the electroneurography value of
the recovery and non-recovery groups was similar (P ¼0.84). In addition, the complete recovery and non-com-
plete recovery groups had comparable electroneurography
values (P ¼ 0.32).
Logistic regression analysis was used to evaluate the
relationships between the electroneurography value and
whether or not there was a recovery, and between the
electroneurography value and whether or not the recovery
was complete. In the Bell’s palsy group, there was no sig-
nificant correlation between the electroneurography value
and whether or not there was a recovery, as well as
between the electroneurography value and whether or not
the recovery was complete (P ¼ 0.85 and P ¼ 0.75,
respectively).
Capability of the electroneurography value to accurately pre-
dict the prognosis of peripheral facial palsy. The sensitivity
and specificity was calculated on the basis of the sup-
Table 2. The initial and final House–Brackmann grades of the
(a) Bell’s palsy (n ¼ 40), and (b) herpes zoster oticus groups
(n ¼ 19)
Final grade
Initial grade
II III IV V
(a)
I 1 12 6 2
II 3 8 6
III
IV 1
V 1
(b)
I 1 5 3
II 1 3 3
III 1 1
IV 1
V
146 D.-H. Lee et al
� 2006 The Authors. Journal compilation � 2006 Blackwell Publishing Limited, Clinical Otolaryngology, 31, 144–148
posed electroneurography values to assess the capability
of the electroneurography value to accurately predict the
prognosis of facial paralysis (Table 3). When calculated
based on electroneurography values of 90%, 80%, 70%,
60% and 50%, their sensitivities in Bell’s palsy were the
same, 90%, and their specificities were £50%. Therefore,
we could not select the proper electroneurography value
that had enough appropriate sensitivity and specificity to
predict the prognosis of facial paralysis accurately in the
Bell’s palsy patients.
Herpes zoster oticus
Patients. During the study period, 29 herpes zoster oticus
patients were admitted for treatment. The patients who
were lost after discharge were excluded and 26 herpes
zoster oticus patients met the inclusion criteria. Electro-
neurography was performed in 19 patients. The herpes
zoster oticus group consisted of 12 males and seven
females with a mean age of 40.3 years (SD, 21.7 years).
The right and left side were involved in 13 and six
patients, respectively. There was no significant difference
of initial and final status between total group and electro-
neurography group (chi-square test; P ¼ 0.83). Table 2b
shows the initial and final status of the herpes zoster oti-
cus group. The chance of a complete recovery was esti-
mated to be 47% in the herpes zoster oticus group
(Fig. 1b).
Correlation between the House–Brackmann grade and
electroneurography value. A Mann–Whitney test was used
to analyse the difference in the electroneurography value
according to whether or not there was a recovery. In the
herpes zoster oticus group, there were no differences in the
electroneurography value between the recovery and non-
recovery groups (P ¼ 0.14), and between the complete
recovery and non-complete recovery groups (P ¼ 0.78).
Logistic regression analysis was used to evaluate the
relationships between the electroneurography value and
whether or not there was a recovery, and between the
electroneurography value and whether or not the recovery
was complete. In the herpes zoster oticus group, there
were no significant correlation between the electroneuro-
graphy value and whether or not there was a recov-
ery, and no correlation between the electroneurography
value and whether or not the recovery was complete
(P ¼ 0.19 and P ¼ 0.82, respectively).
Capability of the electroneurography value to accurately pre-
dict the prognosis of peripheral facial palsy. The sensitivity
and specificity was calculated on the basis of the sup-
posed electroneurography values to assess the capability
of the electroneurography value to accurately predict the
prognosis of facial paralysis (Table 3). When calculated
based on electroneurography values of 90% and 80%,
their sensitivities in the herpes zoster oticus patients were
the same, 90%, but their specificities were £1/3. There-
fore, we could not select the proper electroneurography
Fig. 1. Recovery status of facial paralysis versus electroneurogra-
phy ratio. (a) Bell’s palsy; and (b) herpes zoster oticus groups.
1, completely recovered; 0, not recovered.
Table 3. Sensitivity and specificity of electroneurography in
predicting a complete recovery in Bell’s palsy and herpes zoster
oticus
ENoG (%)
Bell’s palsy Herpes zoster oticus
Sensitivity Specificity Sensitivity Specificity
90 0.0 89.5 22.2 90.0
80 4.8 89.5 33.3 90.0
70 9.5 89.5 33.3 80.0
60 28.6 89.5 44.4 60.0
50 42.9 89.5 55.6 30.0
40 52.4 73.7 55.6 30.0
30 66.7 47.7 77.8 20.0
20 76.2 21.1 88.9 20.0
10 100.0 0.0 100.0 10.0
ENoG in peripheral facial palsy 147
� 2006 The Authors. Journal compilation � 2006 Blackwell Publishing Limited, Clinical Otolaryngology, 31, 144–148
value that had enough appropriate sensitivity and specif-
icity to predict the prognosis of facial paralysis accurately
in the herpes zoster oticus patients.
Discussion
Strengths of the study
May et al.8 reported that if an electroneurography of 25%
or higher is maintained up to the 10th day after onset, a
patient with Bell’s palsy has a 98% chance of achieving a
satisfactory recovery. If an electroneurography of 11–24%
remains, the patient has an 84% chance of achieving a
satisfactory recovery. However, if an electroneurography
of 10% or less remains, the patient has only a 21%
chance of achieving a satisfactory recovery. However,
many cases which did not follow these relations have
resulted in the clinician’s confusion and patient’s anxiety.
In addition, these criteria are not suitable for facial para-
lysis other than Bell’s palsy. Especially, in the herpes zos-
ter oticus, the progress of degeneration is not constant
over time, and there are few reports on its course and
prognosis. This was the first study which evaluated the
correlation between the electroneurography results and
the prognosis in the herpes zoster oticus.
Limitations of the study
This study has three limitations. One limitation was the
limited number of cases, especially, the number of herpes
zoster oticus patients was too small. The other was the
short period of the follow up. This study was a retrospec-
tive study and included only those patients who could be
followed up for at least 3 months or until they had
reached a complete recovery. For the nature of the facial
paralysis, the more long-term follow up might yield the
better results. Lastly, too much Bell’s palsy patients were
lost. Although there was no significant difference of initial
status between 110 patients who were admitted and 55
patients who met the inclusion criteria, these missing data
might be a considerable source of bias.
Comparison with other studies
These results were different from those reported by
Chow,7 who noted that Bell’s palsy patients with electro-
neurography values £72.63% had a ‡90% chance of
recovery to House–Brackmann grade II or better within
2 months. He also noted that the sensitivity and specifici-
ty of electroneurography in predicting a good prognosis
in patients with Bell’s palsy were 82% and 100%, respect-
ively.
Conclusion
In conclusion, the electroneurography value performed
between day 7 and 10 for Bell’s palsy or day 10 and 14
for herpes zoster oticus is not a precise prognostic indica-
tor. The clinical implications of its use are possibly to
counsel and relieve the patients’ psychosocial distress.
However, it is not accurate or reliable enough to deter-
mine the prognosis of facial paralysis quantitatively.
Conflict of interest
None declared.
References
1 Esslen E. (1973) Electrodiagnosis of facial palsy. In Surgery
of the Facial Nerve. A. Miehke (ed), pp. 45–51. W.B. Saunders,
Philadelphia, PA
2 Thomander L. & Stalberg, E. (1981) Electroneurography in the
prognostication of Bell’s palsy. Acta Otolaryngol. 92, 221–237
3 May M., Blumenthal, F. & Klein, SR. (91983) Acute Bell’s palsy:
prognostic value of evoked electromyography, maximal stimula-
tion and other electrical tests. Am. J. Otol. 5, 1–7
4 Fisch U. (1984) Prognostic value of electrical tests in acute facial
paralysis. Am. J. Otol. 5, 494–498
5 Sillman J.S., Niparko, J.K. & Lee, S.S. et al. (1992) Prognostic
value of evoked and standard electromyography in acute facial
paralysis. Otolaryngol. Head Neck Surg. 107, 377–381
6 Smith I.M., Maynard, C. & Mountain, R.E. et al. (1994) The
prognostic value of facial electroneurography in Bell’s palsy. Clin
Otolaryngol. 19, 201–203
7 Chow L.C., Tam, R.C. & Li, M.F. (2002) Use of electroneuro-
graphy as a prognostic indicator of Bell’s palsy in Chinese
patients. Otol. Neurotol. 23, 598–601
8 May M. & Shambaugh, G.E. (1991) Facial nerve paralysis. In
Otolaryngology, 3rd edn, M.M. Paparella, D.A. Shumrick, J.L.
Gluckman & W.L. Meyerhoff (eds). pp. 1106. W.B. Saunders,
Philadelphia, PA
9 House J. & Bracjmann, D.E. (1985) Facial nerve grading system.
Otolaryngol. Head Neck Surg. 92, 146
148 D.-H. Lee et al
� 2006 The Authors. Journal compilation � 2006 Blackwell Publishing Limited, Clinical Otolaryngology, 31, 144–148